Venting Effects on Speech Performance
1 other identifier
interventional
19
1 country
1
Brief Summary
This study aims to gather behavioral data on the effect of earmold venting on speech performance in noise with a new noise reduction feature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2024
CompletedFirst Submitted
Initial submission to the registry
November 26, 2024
CompletedFirst Posted
Study publicly available on registry
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 23, 2025
CompletedMay 4, 2025
November 1, 2024
2 months
November 26, 2024
May 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
AZ Bio Sentences
Sentences will be presented at a pre-determined Signal-to-Noise Ratio (SNR). The SNR will be the same for all three conditions (Power dome, Vented dome, Open dome). Percent correct will be calculated for all conditions. A higher percentage indicates better performance.
1 day
Study Arms (1)
Experimental
EXPERIMENTALAll participants will be tested using all three types of domes: Power, Vented, Open.
Interventions
Receiver-In-Canal hearing aid type that is coupled with either a custom earmold or a dome.
Eligibility Criteria
You may qualify if:
- years of age
- Experienced hearing aid users
- N3-N4 hearing loss
- Fluent in English; ability to read and write in English
- Able to complete complex tasks
- Willing and able to provide informed consent
- Available for the data collection period
You may not qualify if:
- Self-reported active ear-related pathology (otorrhea, dizziness, sudden hearing loss or worsening of hearing, otalgia)
- Visible deformity of the ear
- Chronic, severe tinnitus
- Unilateral hearing loss
- Cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sonova AGlead
Study Sites (1)
Phonak Audiology Research Center
Aurora, Illinois, 60504, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Participants will know they are being fit with hearing aid, but will not be told which vent size or dome they are being fit with for any of the tests. The investigator scoring the speech test will not know which vent size/dome participant is wearing.
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2024
First Posted
December 2, 2024
Study Start
November 11, 2024
Primary Completion
January 23, 2025
Study Completion
January 23, 2025
Last Updated
May 4, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared.